Results 251 to 260 of about 440,532 (310)
Antifungal potential of naphthoquinone derivatives: screening of shikonin-based compounds and mechanistic insights into 5,8-dihydroxy-1,4-naphthoquinone against <i>Candida albicans in vitro</i> and <i>in vivo</i>. [PDF]
Microbiol SpectrChen Q +17 more
europepmc +1 more source
An Evolving Challenge: Fungal Infections in the Contemporary ICU. [PDF]
J Fungi (Basel)Soubani AO.
europepmc +1 more source
Rezafungin for the treatment of invasive candidiasis secondary to esophagogastric anastomotic leak: clinical success in a complex situation. [PDF]
Rev Esp QuimioterEstévez A +4 more
europepmc +1 more source
Trends in candidemia and antifungal resistance: a nine-year single-center study in Turkey. [PDF]
BMC Infect DisYazgan Z, Aygün G.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Microbiology, 2022
Fungi have a profound impact on human health, leading to billions of infections and millions of deaths worldwide each year. Exacerbating the public health burden is the continued emergence of drug-resistant fungal pathogens coupled with a dearth of treatment options to combat serious infections.
Nicole, Robbins, Leah E, Cowen
openaire +2 more sources
Fungi have a profound impact on human health, leading to billions of infections and millions of deaths worldwide each year. Exacerbating the public health burden is the continued emergence of drug-resistant fungal pathogens coupled with a dearth of treatment options to combat serious infections.
Nicole, Robbins, Leah E, Cowen
openaire +2 more sources
Biochemical Pharmacology, 2017
The need for new antifungal agents is undeniable. Current therapeutic choices for the treatment of invasive fungal infections are limited to three classes of drugs. Most used antifungal agents are not completely effective due to the development of resistance, host toxicity and undesirable side effects that limit their use in medical practice.
Sonia, Campoy, José L, Adrio
openaire +2 more sources
The need for new antifungal agents is undeniable. Current therapeutic choices for the treatment of invasive fungal infections are limited to three classes of drugs. Most used antifungal agents are not completely effective due to the development of resistance, host toxicity and undesirable side effects that limit their use in medical practice.
Sonia, Campoy, José L, Adrio
openaire +2 more sources
Pediatric Clinics of North America, 1983
When the decision to treat a fungal infection is made, there are several antifungal agents available for use. AmB remains the first-line drug in the treatment of most systemic fungal infections. Miconazole should be used to treat patients who cannot tolerate AmB or who are infected with AmB-resistant organisms.
M H, Koldin, G, Medoff
openaire +2 more sources
When the decision to treat a fungal infection is made, there are several antifungal agents available for use. AmB remains the first-line drug in the treatment of most systemic fungal infections. Miconazole should be used to treat patients who cannot tolerate AmB or who are infected with AmB-resistant organisms.
M H, Koldin, G, Medoff
openaire +2 more sources
Medical Journal of Australia, 2007
The four main classes of antifungal drugs are the polyenes, azoles, allylamines and echinocandins. Clinically useful "older" agents include topical azole formulations (for superficial yeast and dermatophyte infections), first-generation triazoles (fluconazole and itraconazole, for a range of superficial and invasive fungal infections), amphotericin B ...
Sharon C A, Chen, Tania C, Sorrell
openaire +2 more sources
The four main classes of antifungal drugs are the polyenes, azoles, allylamines and echinocandins. Clinically useful "older" agents include topical azole formulations (for superficial yeast and dermatophyte infections), first-generation triazoles (fluconazole and itraconazole, for a range of superficial and invasive fungal infections), amphotericin B ...
Sharon C A, Chen, Tania C, Sorrell
openaire +2 more sources
Applied Microbiology and Biotechnology, 2002
The search for new drugs against fungal infections is a major challenge to current research in mycotic diseases. The present article reviews the current types of antifungal infections, the current scenario of antifungal antibiotics, and the need and approaches to search for newer antifungal antibiotics and antifungal drug targets.
M, Gupte, P, Kulkarni, B N, Ganguli
openaire +2 more sources
The search for new drugs against fungal infections is a major challenge to current research in mycotic diseases. The present article reviews the current types of antifungal infections, the current scenario of antifungal antibiotics, and the need and approaches to search for newer antifungal antibiotics and antifungal drug targets.
M, Gupte, P, Kulkarni, B N, Ganguli
openaire +2 more sources